AGC Asahi Glass (AGC), a manufacturer of glass, chemicals and high-tech materials, is acquiring CMC Biologics, a clinical and commercial manufacturer of monoclonal antibodies, coagulation factors and other therapeutic proteins in a deal valued at JPY60 billion ($510 million).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
